S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
S&P 500   3,094.04 (+0.07%)
DOW   27,783.59 (+0.33%)
QQQ   201.59 (+0.02%)
AAPL   264.47 (+1.02%)
FB   193.19 (-0.66%)
MSFT   147.31 (+0.16%)
GOOGL   1,296.18 (-0.08%)
AMZN   1,753.11 (-1.40%)
CGC   18.50 (-3.90%)
NVDA   208.57 (-0.50%)
MU   46.30 (-1.28%)
BABA   182.48 (-2.40%)
GE   11.29 (-1.14%)
TSLA   346.11 (-1.09%)
T   39.16 (-0.03%)
AMD   37.52 (+2.21%)
F   8.81 (-2.54%)
ACB   3.55 (-0.56%)
PRI   128.60 (-1.04%)
NFLX   283.11 (-3.05%)
BAC   32.79 (-0.91%)
GILD   63.33 (-1.54%)
DIS   148.72 (+7.32%)
Log in

Medidata Solutions Stock Price, Forecast & Analysis (NASDAQ:MDSO)

$92.22
-0.02 (-0.02 %)
(As of 10/28/2019)
Today's Range
$92.21
Now: $92.22
$92.26
50-Day Range
$91.39
MA: $91.90
$92.25
52-Week Range
$60.10
Now: $92.22
$98.60
Volume7.35 million shs
Average Volume1.24 million shs
Market Capitalization$5.76 billion
P/E Ratio96.06
Dividend YieldN/A
Beta1.22
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner support, and e-learning and training. Read More…

Industry, Sector and Symbol

Industry Prepackaged software
Sub-IndustryHealth Care Technology
SectorMedical
Current SymbolNASDAQ:MDSO
CUSIP58471A10
Phone212-918-1800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$635.70 million
Cash Flow$1.69 per share
Book Value$10.32 per share

Profitability

Net Income$51.92 million

Miscellaneous

Employees1,998
Market Cap$5.76 billion
Next Earnings Date2/10/2020 (Estimated)
OptionableOptionable

Receive MDSO News and Ratings via Email

Sign-up to receive the latest news and ratings for MDSO and its competitors with MarketBeat's FREE daily newsletter.


Medidata Solutions (NASDAQ:MDSO) Frequently Asked Questions

What is Medidata Solutions' stock symbol?

Medidata Solutions trades on the NASDAQ under the ticker symbol "MDSO."

How were Medidata Solutions' earnings last quarter?

Medidata Solutions Inc (NASDAQ:MDSO) issued its quarterly earnings results on Monday, July, 22nd. The company reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.31. The firm earned $180.50 million during the quarter, compared to the consensus estimate of $179.95 million. Medidata Solutions had a return on equity of 8.64% and a net margin of 6.43%. The company's revenue was up 15.8% on a year-over-year basis. During the same period last year, the company earned $0.43 earnings per share. View Medidata Solutions' Earnings History.

When is Medidata Solutions' next earnings date?

Medidata Solutions is scheduled to release their next quarterly earnings announcement on Monday, February 10th 2020. View Earnings Estimates for Medidata Solutions.

What price target have analysts set for MDSO?

8 Wall Street analysts have issued 12 month price targets for Medidata Solutions' stock. Their forecasts range from $70.00 to $96.00. On average, they expect Medidata Solutions' stock price to reach $85.91 in the next year. This suggests that the stock has a possible downside of 6.8%. View Analyst Price Targets for Medidata Solutions.

What is the consensus analysts' recommendation for Medidata Solutions?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medidata Solutions in the last year. There are currently 8 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Medidata Solutions.

Has Medidata Solutions been receiving favorable news coverage?

Media stories about MDSO stock have trended very negative this week, InfoTrie Sentiment reports. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Medidata Solutions earned a coverage optimism score of -3.2 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for Medidata Solutions.

Are investors shorting Medidata Solutions?

Medidata Solutions saw a increase in short interest during the month of October. As of October 31st, there was short interest totalling 6,100,000 shares, an increase of 9.9% from the September 30th total of 5,550,000 shares. Based on an average daily volume of 760,200 shares, the days-to-cover ratio is currently 8.0 days. Approximately 10.2% of the shares of the stock are short sold. View Medidata Solutions' Current Options Chain.

Who are some of Medidata Solutions' key competitors?

What other stocks do shareholders of Medidata Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medidata Solutions investors own include NVIDIA (NVDA), Applied Materials (AMAT), Gilead Sciences (GILD), Allergan (AGN), salesforce.com (CRM), IBM (IBM), Alphabet (GOOG), Intel (INTC), Ionis Pharmaceuticals (IONS) and Western Digital (WDC).

Who are Medidata Solutions' key executives?

Medidata Solutions' management team includes the folowing people:
  • Mr. Tarek A. Sherif, Co-Founder, Chairman & CEO (Age 57)
  • Mr. Glen M. de Vries, Co-Founder, Pres & Director (Age 47)
  • Mr. Rouven Bergmann, Chief Financial Officer (Age 46)
  • Mr. Michael Pray, Exec. VP - Gen. Mang. of Global Sales (Age 53)
  • Ms. Jill Larsen, Exec. VP - HR & Chief HR Officer (Age 46)

Who are Medidata Solutions' major shareholders?

Medidata Solutions' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Syquant Capital Sas (2.48%), ARP Americas LP (1.12%), Assenagon Asset Management S.A. (0.88%), Gabelli Funds LLC (0.63%), Rice Hall James & Associates LLC (0.62%) and Global Thematic Partners LLC (0.55%). Company insiders that own Medidata Solutions stock include Carlos Dominguez, Daniel Patrick Shannon, Lee Shapiro, Michael I Otner, Michael L Capone, Michael Pray, Robert Taylor, Rouven Bergmann and Tarek Sherif. View Institutional Ownership Trends for Medidata Solutions.

Which institutional investors are selling Medidata Solutions stock?

MDSO stock was sold by a variety of institutional investors in the last quarter, including Global Thematic Partners LLC, Russell Investments Group Ltd., Arcadia Investment Management Corp MI, SG Americas Securities LLC, Envestnet Asset Management Inc., Rice Hall James & Associates LLC, Tocqueville Asset Management L.P. and Pacer Advisors Inc.. Company insiders that have sold Medidata Solutions company stock in the last year include Daniel Patrick Shannon, Michael Pray, Robert Taylor and Rouven Bergmann. View Insider Buying and Selling for Medidata Solutions.

Which institutional investors are buying Medidata Solutions stock?

MDSO stock was purchased by a variety of institutional investors in the last quarter, including Syquant Capital Sas, Assenagon Asset Management S.A., Candriam Luxembourg S.C.A., ARP Americas LP, Gabelli Funds LLC, First Trust Advisors LP, GABELLI & Co INVESTMENT ADVISERS INC. and Tibra Equities Europe Ltd. View Insider Buying and Selling for Medidata Solutions.

How do I buy shares of Medidata Solutions?

Shares of MDSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Medidata Solutions' stock price today?

One share of MDSO stock can currently be purchased for approximately $92.22.

How big of a company is Medidata Solutions?

Medidata Solutions has a market capitalization of $5.76 billion and generates $635.70 million in revenue each year. The company earns $51.92 million in net income (profit) each year or $0.96 on an earnings per share basis. Medidata Solutions employs 1,998 workers across the globe.View Additional Information About Medidata Solutions.

What is Medidata Solutions' official website?

The official website for Medidata Solutions is http://www.mdsol.com/.

How can I contact Medidata Solutions?

Medidata Solutions' mailing address is 350 HUDSON ST. 9TH FLOOR, NEW YORK NY, 10014. The company can be reached via phone at 212-918-1800 or via email at [email protected]


MarketBeat Community Rating for Medidata Solutions (NASDAQ MDSO)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  480 (Vote Outperform)
Underperform Votes:  401 (Vote Underperform)
Total Votes:  881
MarketBeat's community ratings are surveys of what our community members think about Medidata Solutions and other stocks. Vote "Outperform" if you believe MDSO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDSO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel